Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion type Assertion NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_head.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion description "[Statistically significant association with breast cancer risk was observed for rs1130409 homozygous mutant GG [odds ratio (OR) 3.35, 95% confidence interval (CI) 1.36-8.26), heterozygous GT (OR 2.42, 95% CI 1.56-3.76), and combined mutant (GT + GG) (OR 2.52, 95% CI 1.65-3.86] genotypes and rs25487 homozygous mutant AA (OR 2.91, 95% CI 1.66-5.10) and combined mutant (AA + AG) (OR 1.41, 95% CI 0.903-2.19) genotypes, whereas protective association was exhibited by rs1799782 homozygous mutant CC (OR 0.413, 95% CI 0.082-2.08), heterozygous TC (OR 0.351, 95% CI 0.189-0.650), and combined mutant (TC + CC) (OR 0.357, 95% CI 0.199-0.641) genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_provenance.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion evidence source_evidence_literature NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_provenance.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion SIO_000772 18669164 NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_provenance.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion wasDerivedFrom befree-20150227 NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_provenance.
- NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_assertion wasGeneratedBy ECO_0000203 NP883472.RAVHpbu-8Wqi75UjB7RjKZAIJOnSLhjvcki1mBkCppLL0130_provenance.